1. Home
  2. AXSM vs CHYM Comparison

AXSM vs CHYM Comparison

Compare AXSM & CHYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXSM
  • CHYM
  • Stock Information
  • Founded
  • AXSM 2012
  • CHYM 2012
  • Country
  • AXSM United States
  • CHYM United States
  • Employees
  • AXSM N/A
  • CHYM N/A
  • Industry
  • AXSM Biotechnology: Pharmaceutical Preparations
  • CHYM Finance: Consumer Services
  • Sector
  • AXSM Health Care
  • CHYM Finance
  • Exchange
  • AXSM Nasdaq
  • CHYM Nasdaq
  • Market Cap
  • AXSM 5.9B
  • CHYM 7.0B
  • IPO Year
  • AXSM 2015
  • CHYM 2025
  • Fundamental
  • Price
  • AXSM $131.96
  • CHYM $18.05
  • Analyst Decision
  • AXSM Strong Buy
  • CHYM Buy
  • Analyst Count
  • AXSM 19
  • CHYM 13
  • Target Price
  • AXSM $174.47
  • CHYM $36.58
  • AVG Volume (30 Days)
  • AXSM 465.7K
  • CHYM 2.6M
  • Earning Date
  • AXSM 11-03-2025
  • CHYM 11-05-2025
  • Dividend Yield
  • AXSM N/A
  • CHYM N/A
  • EPS Growth
  • AXSM N/A
  • CHYM N/A
  • EPS
  • AXSM N/A
  • CHYM N/A
  • Revenue
  • AXSM $495,033,000.00
  • CHYM $1,943,976,000.00
  • Revenue This Year
  • AXSM $63.76
  • CHYM $30.52
  • Revenue Next Year
  • AXSM $54.57
  • CHYM $20.51
  • P/E Ratio
  • AXSM N/A
  • CHYM N/A
  • Revenue Growth
  • AXSM 69.83
  • CHYM 92.69
  • 52 Week Low
  • AXSM $75.56
  • CHYM $17.00
  • 52 Week High
  • AXSM $139.13
  • CHYM $44.94
  • Technical
  • Relative Strength Index (RSI)
  • AXSM 61.56
  • CHYM N/A
  • Support Level
  • AXSM $127.17
  • CHYM N/A
  • Resistance Level
  • AXSM $136.23
  • CHYM N/A
  • Average True Range (ATR)
  • AXSM 4.18
  • CHYM 0.00
  • MACD
  • AXSM 0.50
  • CHYM 0.00
  • Stochastic Oscillator
  • AXSM 74.50
  • CHYM 0.00

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

About CHYM Chime Financial Inc. Class A Common Stock

Chime Financial Inc is a financial technology company that believes in core banking services.

Share on Social Networks: